Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 817,966 | 628,371 | 1,233,032 | 1,079,979 | 805,593 |
| Marketable Securities | 139,148 | 189,213 | 38,839 | 46,948 | 119,146 |
| Receivables | 262,245 | 243,593 | 232,609 | 180,340 | 189,115 |
| Inventories | 35,623 | 23,549 | 10,965 | 25,550 | 32,331 |
| Other current assets | 182,130 | 176,093 | 182,316 | 161,357 | 195,651 |
| TOTAL | $1,487,804 | $1,310,894 | $1,760,498 | $1,547,196 | $1,381,540 |
| Non-Current Assets | |||||
| PPE Net | 481,581 | 513,481 | 534,381 | 541,963 | 537,432 |
| Investments And Advances | 97,812 | 102,514 | 62,819 | 52,149 | 179,587 |
| Intangibles | 575,836 | 477,412 | 463,584 | 489,376 | 515,720 |
| Other Non-Current Assets | 336,733 | 285,247 | 284,405 | 286,641 | 207,470 |
| TOTAL | $1,491,962 | $1,378,654 | $1,345,189 | $1,370,129 | $1,440,209 |
| Total Assets | $2,979,766 | $2,689,548 | $3,105,687 | $2,917,325 | $2,821,749 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,925 | 14,171 | 17,779 | 12,617 | 15,212 |
| Accrued Expenses | 351,399 | 230,237 | 262,728 | 219,974 | 268,144 |
| Other current liabilities | 31,505 | 18,588 | 18,473 | 15,436 | 19,991 |
| TOTAL | $422,226 | $277,518 | $315,717 | $267,109 | $306,853 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 184,368 | 161,199 | 178,142 | 211,555 | 201,512 |
| TOTAL | $185,356 | $161,010 | $185,738 | $211,811 | $201,866 |
| Total Liabilities | $607,582 | $438,528 | $501,455 | $478,920 | $508,719 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,276 | 95,958 | 101,161 | 100,349 | 100,201 |
| Common Shares | 94 | 94 | 100 | 99 | 99 |
| Retained earnings | 2,391,990 | 2,297,730 | 2,607,909 | 2,443,138 | 2,327,877 |
| Other shareholders' equity | -19,900 | -46,804 | -3,777 | -4,832 | -14,946 |
| TOTAL | $2,372,184 | $2,251,020 | $2,604,232 | $2,438,405 | $2,313,030 |
| Total Liabilities And Equity | $2,979,766 | $2,689,548 | $3,105,687 | $2,917,325 | $2,821,749 |